ELAVL1 and cancer: Mechanistically, our RIP-Chip and transcriptomics data showed a global dysregulation of several signaling pathways and molecular regulators in these cancer cells, including the HIPPO-YAP/TAZ, PI3K/AKT/mTOR, RAS/RAF-MEK-ERK, and Wnt/β-catenin pathways and bromodomain regulation of gene transcription, while our focused analyses revealed that regulation by HuR of specific components of these pathways likely led to the aberrant signaling.